[go: up one dir, main page]

TN2010000535A1 - Agent for induction /maintenance of remission - Google Patents

Agent for induction /maintenance of remission

Info

Publication number
TN2010000535A1
TN2010000535A1 TNP2010000535A TN2010000535A TN2010000535A1 TN 2010000535 A1 TN2010000535 A1 TN 2010000535A1 TN P2010000535 A TNP2010000535 A TN P2010000535A TN 2010000535 A TN2010000535 A TN 2010000535A TN 2010000535 A1 TN2010000535 A1 TN 2010000535A1
Authority
TN
Tunisia
Prior art keywords
remission
induction
maintenance
agent
immune disease
Prior art date
Application number
TNP2010000535A
Other languages
French (fr)
Inventor
Kazuhiko Kuriyama
Tomoyuki Kago
Tokutaro Yasue
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2009/059176 external-priority patent/WO2009142195A1/en
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of TN2010000535A1 publication Critical patent/TN2010000535A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed is a method for inducing/maintaining remission of an immune disease, which can reduce serious adverse side effects and stress in a patient. After the induction of remission of an immune disease with a biological substance or a nucleic acid synthesis inhibitor, a sphingosine-1-phosphate receptor agonist is used.
TNP2010000535A 2009-05-19 2010-11-19 Agent for induction /maintenance of remission TN2010000535A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2009/059176 WO2009142195A1 (en) 2008-05-20 2009-05-19 Agent for induction/maintenance of remission

Publications (1)

Publication Number Publication Date
TN2010000535A1 true TN2010000535A1 (en) 2012-05-24

Family

ID=55024628

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000535A TN2010000535A1 (en) 2009-05-19 2010-11-19 Agent for induction /maintenance of remission

Country Status (1)

Country Link
TN (1) TN2010000535A1 (en)

Similar Documents

Publication Publication Date Title
EP2232430A4 (en) Medical product management methods
IL222252A (en) System, assembly and method for the detection and diagnosis of biological rhythm disorders
MX2012001310A (en) Methods for providing beneficial effects to the oral cavity.
TN2011000281A1 (en) Dosage regimen of an s1p receptor agonist
ZA201004848B (en) Method for the production of disubstituted imidazolium salts
MX2010000724A (en) Method for reducing intracranial pressure.
GB201301596D0 (en) Method and system for pacing, ack'ing, timing, and handicapping (path) for simultaneous receipt of documents
CL2012002424A1 (en) Method for treating rheumatoid artitris which comprises administering to the patient laquinimod and methotrexate orally; pharmaceutical composition that comprises them.
HU0800434D0 (en) Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
ZA201005905B (en) Methods,dosage forms,and kits for administering ziprasidone without food
UA110626C2 (en) METHOD OF PREPARATION OF PAN-INHIBITORS OF CYCLINOSAL KINASE OF FORMULA (I) AND ALSO INTERMEDIATE PRODUCTS OF THIS OBTAINING PROCESS
IL229607B (en) Method for the diagnosis of gaucher's disease
GB2469547B (en) Method, system and software product for the measurement of heart rate variability
TN2010000535A1 (en) Agent for induction /maintenance of remission
EP3153861A3 (en) Biomarkers for predicting response to a cancer vaccine
SG179067A1 (en) 13c-mr detection using hyperpolarised 13c-fructose
MX2010006890A (en) Method for predicting responsiveness to a pharmaceutical therapy for obesity.
MY154685A (en) Agent for maintanance of induced remission
WO2011103182A3 (en) Imaging methods for assessment and quantification of vaccination and in vivo antigen capture
MY156251A (en) Glucuronidated acetaminophen as a marker of hepatic disorders
EP2462554A4 (en) Method for quantifying the extent of human-introduced variability in medical test data
MX2012000952A (en) Method for predicting weight gain associated with a pharmaceutical therapy.
WO2011056599A3 (en) Caged ceramide-1-phosphate derivatives
UA37523U (en) Method for predicting consequences of ischemic stroke
UA37524U (en) Method for predicting consequences of ischemic stroke